Libertas 7 SA
MAD:LIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Libertas 7 SA
MAD:LIB
|
ES |
|
Alma Metals Ltd
ASX:ALM
|
AU |
|
Uniti Group Inc
NASDAQ:UNIT
|
US |
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
AU |
|
L
|
Landmark Land Co Inc
OTC:LLND
|
US |
|
N
|
NetApp Inc
XMUN:NTA
|
US |
|
B
|
Black Rock Coffee Bar Inc
NASDAQ:BRCB
|
US |
|
Extendicare Inc
TSX:EXE
|
CA |
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LIB's stock price target?
Not Available
LIB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Libertas 7 SA?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Libertas 7 SA?
Projected CAGR
21%
The compound annual growth rate for Gross Profit over the next 3 years is 21%.
What is the Operating Income forecast for Libertas 7 SA?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 3 years is 27%.
What is the Pre-Tax Income forecast for Libertas 7 SA?
Projected CAGR
21%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 21%.
What is the Net Income forecast for Libertas 7 SA?
Projected CAGR
22%
The compound annual growth rate for Net Income over the next 3 years is 22%.